Teladoc Health Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio0.611.371.597.2326.50
P/B Ratio1.051.531.660.921.82
Price/FCF5.5310.5422.1679.26
Price/OCF5.3310.1920.2375.77
Enterprise Value Ratios
EV/Revenue0.741.581.897.4626.34
EV/EBITDA60.2194.47
EV/FCF6.7512.1726.2581.75
Profitability & Returns
Return on Equity (ROE)-0.52%-0.10%-1.49%-0.03%-0.06%
Return on Assets (ROA)-0.03%-0.03%-0.01%-0.01%-0.03%
Return on Capital Employed (ROCE)-0.08%-0.05%-0.06%-0.01%-0.02%
Leverage & Solvency Ratios
Debt/Equity1.060.690.690.080.09
Debt/EBITDA35.2326.96142.99
Debt/FCF5.604.709.187.02
Liquidity Ratios
Current Ratio1.773.543.293.703.19
Quick Ratio1.623.222.893.282.87
Efficiency Ratios
Asset Turnover0.650.600.220.120.11
Inventory Turnover22.2117.7011.5010.04
Yield & Distribution Ratios
Earnings Yield-0.64%-0.06%-3.57%-0.03%-0.02%
FCF Yield0.18%0.09%0.05%0.01%0.00%
Buyback Yield-0.04%-0.02%-0.03%-0.73%-0.26%